Build a Bright future for your Brain Today!
At NewBrain, we’re revolutionizing brain health through innovative stem cell research aimed at treating neurological diseases like dementia, sclerosis, and traumatic brain injuries.
Our focus is to harness the regenerative power of stem cells to treat brain injuries and neurodegenerative diseases like Alzheimer’s, sclerosis, and age-related cognitive decline.
Through rigorous scientific research, we aim to offer effective treatments that improve the lives of millions globally.
Innovative Solutions: Stem Cell Therapy
Stem cells are at the forefront of regenerative medicine. These cells have the unique ability to repair damaged brain tissue, offering hope for those suffering from debilitating conditions. Our research focuses on the application of neural stem cells to target damaged neurons, regenerate brain tissue, and improve cognitive function.
-
Dementia (Alzheimer’s, Parkinson’s)
-
Traumatic brain injury (TBI)
-
Multiple sclerosis
-
Stroke recovery
-
Age-related cognitive decline
Our proprietary research leverages stem cell technology to create innovative treatments that could restore brain function. By working closely with world-class scientists and medical experts, we aim to fast-track our progress toward clinical trials.
Alexandr VARVARENKO
Scientific Foundation
& Partnerships
Our scientific approach is grounded in the latest advancements in stem cell research. We focus on developing neural stem cells with the ability to regenerate neurons, offering hope for neurological recovery after brain injuries and age-related conditions.
We collaborate with top medical institutions to ensure our research meets the highest scientific standards. Our upcoming clinical trials aim to validate the potential of our treatments in real-world applications, focusing on conditions like dementia and TBI.
Inspired by pioneering work from companies like ReNeuron and Pacific Neuroscience Institute, we are leveraging similar approaches to drive our research forward.
Why Invest in NewBrain?
-
The Future of Brain Health
The global burden of brain-related diseases is increasing, especially as the population ages. Our innovative approach to stem cell therapies offers the potential to not only treat but also prevent these conditions, opening up a vast market for revolutionary treatments. -
Investment Opportunities
Investing in NewBrain means supporting life-changing therapies with the potential to transform the field of brain health. We are currently in the research and development phase, and early-stage investment will help bring our treatments to market faster. -
Market Potential
With an increasing global focus on aging populations and the rise of neurodegenerative diseases, the demand for innovative brain health solutions is growing exponentially. We are positioned to lead this change with our pioneering stem cell technologies.
Our immediate goal is to enter clinical trials within the next 18–24 months, focusing on Alzheimer's and traumatic brain injury.
Over the next 5 years, we aim to introduce our treatments to the market, providing effective solutions for millions of patients worldwide.
Our Path to Clinical TrialsMeet the Team
Leadership & Expertise
Led by experts in neuroscience, regenerative medicine, and stem cell technology, the NewBrain team brings together decades of experience in medical innovation.
We are supported by leading researchers and institutions who guide our mission with their scientific expertise and insight.
Get Involved: Invest in the Future of Brain Health
We invite you to join us in our journey to revolutionize brain health. Whether you’re an investor, researcher, or healthcare professional, your support will help us bring these life-changing treatments to those who need them most.
NewBrain is led by professionals with years of experience in neurobiology and regenerative medicine, providing a solid scientific foundation for our research.
Innovations in Neurobiology
NewBrain is developing advanced stem cell therapies that can transform the treatment of neurological diseases such as dementia and traumatic brain injuries.
NewBrain Foundation VZW
Antwerp, Belgium
Bank account: BE86 9734 9585 5950
Bank: Argenta Bank, Belgium
Swift: ARSPBE22XXX